| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AA 3 Adequate treatment for early breast cancer in LMICs?
|
Barrios, C.
|
|
|
68 |
S |
p. S14
|
article
|
| 2 |
AA 1 Modern radiotherapy for early breast cancer
|
Fastner, G.
|
|
|
68 |
S |
p. S12-S13
|
article
|
| 3 |
AA 3 New drugs on the horizon for early breast cancer
|
Martin, M.
|
|
|
68 |
S |
p. S13-S14
|
article
|
| 4 |
AA2 Overtreatment in early breast cancer – who is at risk?
|
Senkus, E.
|
|
|
68 |
S |
p. S13
|
article
|
| 5 |
Author Index
|
|
|
|
68 |
S |
p. S137-S146
|
article
|
| 6 |
Editorial Board
|
|
|
|
68 |
S |
p. ii
|
article
|
| 7 |
P180 A associated of suspicious lymph node by ultrasound/mammogram and sentinel lymph node followed by ultrasound guide clip-node placement in Early Breast cancer patient
|
Chirappapha, P.
|
|
|
68 |
S |
p. S87
|
article
|
| 8 |
P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes
|
Johnston, S.
|
|
|
68 |
S |
p. S22-S23
|
article
|
| 9 |
P215 Absent post-treatment changes in negative sentinel lymph nodes and regional recurrence in initially node positive breast cancer patients
|
Pislar, N.
|
|
|
68 |
S |
p. S101-S102
|
article
|
| 10 |
P096 Accelerated Partial Breast Irradiation Versus Whole Breast Irradiation Using 3-Dimensional Conformal External Beam Radiation Therapy: Long term outcomes data of a study from India
|
Yadav, B.S.
|
|
|
68 |
S |
p. S51-S52
|
article
|
| 11 |
P074 Access with website to prevention and screening program for tlemcenian woman
|
Ghomari, S.
|
|
|
68 |
S |
p. S43
|
article
|
| 12 |
P297 Accuracy of Vacuum Assisted Excision in minimizing overtreatment of breast lesions with uncertain malignant potential (B3 lesions) from a single institution
|
Sarker, M.
|
|
|
68 |
S |
p. S134
|
article
|
| 13 |
P246 A comparative study between round block technique and standard wide local excision in patients with breast cancer
|
Ibrahim, M.
|
|
|
68 |
S |
p. S113
|
article
|
| 14 |
P109 Addition of platinum analogues to neoadjuvant chemotherapy improving pathologic complete response among triple negative breast cancer patients. Real World Evidence
|
Ramos, E. De Jesus
|
|
|
68 |
S |
p. S56
|
article
|
| 15 |
P047 Adenomyoepithelioma of the breast: a case series of a rare pathology
|
Ruecker, K.
|
|
|
68 |
S |
p. S33-S34
|
article
|
| 16 |
P019 Adjuvant chemotherapy after radical surgery and immediate reconstruction
|
Gortari, M. Ciaurriz
|
|
|
68 |
S |
p. S24
|
article
|
| 17 |
P002 Adjuvant chemotherapy for resected early-stage triple negative breast cancer
|
Solinas, C.
|
|
|
68 |
S |
p. S15
|
article
|
| 18 |
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction
|
Gortari, M. Ciaurriz
|
|
|
68 |
S |
p. S52
|
article
|
| 19 |
P237 Analysis of factors with impact on short stay surgery for patients operated for breast cancer during COVID 19 pandemic
|
Maksimovic, Z.
|
|
|
68 |
S |
p. S109-S110
|
article
|
| 20 |
P070 An update on radiation-induced angiosarcoma of the breast: A diagnostic and management challenge
|
Zhao, C.L.
|
|
|
68 |
S |
p. S42
|
article
|
| 21 |
P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?
|
Beltran-Bless, A.-A.
|
|
|
68 |
S |
p. S127
|
article
|
| 22 |
P111 A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)
|
Harbeck, N.
|
|
|
68 |
S |
p. S57
|
article
|
| 23 |
P183 A Pivotal Phase III Randomized Clinical Trial to Evaluate the Safety and Efficacy of the Fluorescent Imaging Agent PD G 506 A for the Real-time Visualization of Cancer During Breast Conserving Surgery
|
Mamounas, E.
|
|
|
68 |
S |
p. S88
|
article
|
| 24 |
P245 Apocrine breast carcinoma. a single institution experience and literature review
|
Salemis, N.
|
|
|
68 |
S |
p. S113
|
article
|
| 25 |
P021 A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study)
|
Savard, M.-F.
|
|
|
68 |
S |
p. S24-S25
|
article
|
| 26 |
P044 A rapid point-of-care test kit for improved clinical management of patients with breast cancer and associated co-morbidities: Significance of the MTHFR-homocysteine pathway
|
Baatjes, K.
|
|
|
68 |
S |
p. S32-S33
|
article
|
| 27 |
P009 A real-world prospective observational multi-national study in adult patients with breast cancer treated with extended adjuvant neratinib: NERLYFE study
|
Harbeck, N.
|
|
|
68 |
S |
p. S18-S19
|
article
|
| 28 |
P253 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER+/human epidermal growth factor receptor 2 (HER2)- breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study
|
Hurvitz, S.A
|
|
|
68 |
S |
p. S116
|
article
|
| 29 |
P229 Assessment of Complication rates in patients undergoing Direct to Implant reconstruction in A single Multidisciplinary unit in Johannesburg South 2022
|
Benn, C.-A.
|
|
|
68 |
S |
p. S107
|
article
|
| 30 |
P274 Association between tamoxifen and incidence of osteoporosis in Korean patients with ductal carcinoma in situ
|
Yoon, C.I.
|
|
|
68 |
S |
p. S125
|
article
|
| 31 |
P048 Association of mtDNA Copy Number Variations with Neoadjuvant in Triple Negative Breast Cancer Patients
|
Manto, K.
|
|
|
68 |
S |
p. S34
|
article
|
| 32 |
P232 A study to evaluate the safety and utility of targeted axillary dissection using Guiding-Marker System
|
Endo, Y.
|
|
|
68 |
S |
p. S108
|
article
|
| 33 |
P059 Awareness among women regarding warning signs and effective screening methods in breast cancer
|
Sha, A.
|
|
|
68 |
S |
p. S38
|
article
|
| 34 |
P061 Awareness among women regarding warning signs and effective screening methods in breast cancer.
|
Katpattil, S.
|
|
|
68 |
S |
p. S38-S39
|
article
|
| 35 |
P117 Axillary residual disease after neoadjuvant treatment according to disease burden in the sentinel lymph node biopsy
|
López-Marín, L.
|
|
|
68 |
S |
p. S59
|
article
|
| 36 |
P116 Axillary residual disease in patients with positive sentinel node after neoadjuvant treatment according to tumor subtype
|
López-Marín, L.
|
|
|
68 |
S |
p. S59
|
article
|
| 37 |
P069 Barriers in the diagnosis and treatment of early breast cancer in a low middle income country (LMIC): an epidemiological profile of breast cancer patients from a teaching hospital in North India
|
Gupta, S.K.
|
|
|
68 |
S |
p. S41-S42
|
article
|
| 38 |
P197 Benign and Borderline Phyllodes: Management and Follow-Up
|
Kinoglou, G.
|
|
|
68 |
S |
p. S94
|
article
|
| 39 |
P258 Breast cancer and endometriosis: correlation between different type and stage. A preliminary study
|
Marsella, V.
|
|
|
68 |
S |
p. S117-S118
|
article
|
| 40 |
P081 Breast cancer in young women
|
Kouadri, N.
|
|
|
68 |
S |
p. S46
|
article
|
| 41 |
P028 Breast cancer: is there an end for the heterogeneous disease?
|
Hidiroglu, M.M.
|
|
|
68 |
S |
p. S27
|
article
|
| 42 |
P060 Breast cancer knowledge and screening practices amongst female in bandung city, west java, indonesia
|
Gaol, D. Lumban
|
|
|
68 |
S |
p. S38
|
article
|
| 43 |
P164 Breast cancer patients aged 70 and over: clinical characteristics, treatment, and prognosis
|
Kim, J.H.
|
|
|
68 |
S |
p. S78-S79
|
article
|
| 44 |
P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
|
Liefers, G.-J.
|
|
|
68 |
S |
p. S21
|
article
|
| 45 |
P255 Breast cancer surgery with ‘pecs block’ technique in the oldest old
|
Roveda, L.
|
|
|
68 |
S |
p. S116-S117
|
article
|
| 46 |
P179 Breast molecular subtypes predict the local recurrence after primary surgery of breast cancer
|
Vachiraprakarnsakul, P.
|
|
|
68 |
S |
p. S86
|
article
|
| 47 |
P230 Breast reconstruction: recurrence in patients with mastectomy and immediate breast reconstruction
|
Gortari, M. Ciaurriz
|
|
|
68 |
S |
p. S107
|
article
|
| 48 |
P178 Breast reconstruction with resorbable scaffold and fat
|
Mastorakos, D.P.
|
|
|
68 |
S |
p. S86
|
article
|
| 49 |
P196 Breast Textured Implants Determine Early T-helper Impairment: BIAL2.20 Study
|
Buonomo, O.C.
|
|
|
68 |
S |
p. S93-S94
|
article
|
| 50 |
P166 Budget impact of MammaPrint® in Patients with primary hormone receptor-positive, HER2-negative and non-metastatic early-stage breast cancer in France
|
Zarca, D.
|
|
|
68 |
S |
p. S79-S80
|
article
|
| 51 |
P296 Can MRI detect PD-L1 expression as accurately as a patohistological specimen?
|
Bartolović, N.
|
|
|
68 |
S |
p. S133
|
article
|
| 52 |
P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial
|
Canino, F.
|
|
|
68 |
S |
p. S60
|
article
|
| 53 |
P275 Cardiovascular Event Free Survival in early breast cancer patients
|
Saidi, M.A.
|
|
|
68 |
S |
p. S125
|
article
|
| 54 |
P024 Cell cycle checkpointkinase2 influences the chemotherapeutic response in breast cancer patients
|
Sarfraz, S.
|
|
|
68 |
S |
p. S25
|
article
|
| 55 |
P292 Cell-free DNA (cfDNA) profiling using Guardant360 in Japanese metastatic breast cancer patients
|
Kawashima, M.
|
|
|
68 |
S |
p. S132
|
article
|
| 56 |
P043 Characteristics and clinical outcomes of patients with HER2-low breast cancer
|
Koh, S.
|
|
|
68 |
S |
p. S32
|
article
|
| 57 |
P154 Characteristics and prognosis of BRCA-associated breast cancers: Results from a single-center observational study in Thailand
|
Sukarayothin, T.
|
|
|
68 |
S |
p. S75-S76
|
article
|
| 58 |
P175 Characteristics and Survival Outcomes of Breast Cancer Patients Discussed at Molecular Tumor Board of European Institute of Oncology
|
Crimini, E.
|
|
|
68 |
S |
p. S84-S85
|
article
|
| 59 |
P114 Characteristics of residual tumor after neoadjuvant chemotherapy (nact)may predict outcomes in patients with triple negative breast cancer (tnbc)
|
Frolova, M.
|
|
|
68 |
S |
p. S58
|
article
|
| 60 |
P293 Classification of abnormal findings on dedicated breast PET for prediction of malignancy
|
Sasada, S.
|
|
|
68 |
S |
p. S132-S133
|
article
|
| 61 |
P036 Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations
|
Chan, J.Y.
|
|
|
68 |
S |
p. S30
|
article
|
| 62 |
P303 Clinical, anatomo-pathological and molecular specificities of breast cancer in women >70 years old about 53 cases in Eastern Algeria. (Monocentric study)
|
Bouguettaya, A.
|
|
|
68 |
S |
p. S135
|
article
|
| 63 |
P101 Clinical feasibility of breast tumor bed irradiation with the Hybrid magnetic resonance linear accelerator 1.5T MR-Linac
|
Mazouni, Z.
|
|
|
68 |
S |
p. S53
|
article
|
| 64 |
P122 Clinical impact of fine needle aspiration cytologyon sentinel node biopsy after preoperative chemotherapy for core needle biopsyproven metastatic lymph nodes
|
Nakamura, R.
|
|
|
68 |
S |
p. S61
|
article
|
| 65 |
P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data
|
Rotem, O.
|
|
|
68 |
S |
p. S81-S82
|
article
|
| 66 |
P147 Clinical, pathological, and prognostic features of male breast cancer. A multicenter study
|
Accomasso, F.
|
|
|
68 |
S |
p. S72
|
article
|
| 67 |
P160 Clinical significance of low-level HER2 expression breast cancer and its clinicopathological features: an analysis of 3547 breast cancer patients
|
Lin, J.
|
|
|
68 |
S |
p. S78
|
article
|
| 68 |
P029 Clinical significance of TILs components in triple negative breast carcinoma
|
Peterko, A.
|
|
|
68 |
S |
p. S27-S28
|
article
|
| 69 |
P112 Clinicopathological factors for predicting tumor response in hormonal positive/HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
|
Yincharoen, P.
|
|
|
68 |
S |
p. S57
|
article
|
| 70 |
P062 Clinico-pathological presentation and peculiar challenges of breast cancer in patients aged less than 40 years [Young Breast Cancer (YBC)]: An experience from a tertiary center of a developing nation
|
Usofi, Z.
|
|
|
68 |
S |
p. S39
|
article
|
| 71 |
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT
|
Kuntaraksa, N.
|
|
|
68 |
S |
p. S96-S97
|
article
|
| 72 |
P033 Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in-situ-hybridization
|
Shanmugalingam, A.
|
|
|
68 |
S |
p. S29
|
article
|
| 73 |
P187 Comparison of long term oncologic outcome of sentinel lymph node mapping methods, dye-only versus dye and radioisotope in breast cancer following neoadjuvant chemotherapy
|
Lim, C.
|
|
|
68 |
S |
p. S90
|
article
|
| 74 |
P252 Comparison of the Effectiveness of Complex Decongestive Therapy Components in the Treatment of Upper Extremity Lymphedema Associated with Breast Cancer
|
Özdilek, S. Eken
|
|
|
68 |
S |
p. S115
|
article
|
| 75 |
P240 Computerized Quantification of Tumor Infiltrating Lymphocyte (TIL) as a prognostic and predictive factor in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial
|
Li, H.
|
|
|
68 |
S |
p. S111
|
article
|
| 76 |
P186 Confirmatory study of nanoparticle-assisted axillary staging in breast cancer patients who received neoadjuvant chemotherapy: expanded indication and reduced axillary intervention
|
He, T.
|
|
|
68 |
S |
p. S89-S90
|
article
|
| 77 |
P162 Contralateral Breast Cancer in BRCA 1 vs 2 Mutation Carriers
|
Girardi, A.
|
|
|
68 |
S |
p. S78
|
article
|
| 78 |
P298 Contrast-enhanced mammography(CEM) with magnetic tracer as an alternative to MRI
|
Benn, C.-A.
|
|
|
68 |
S |
p. S134
|
article
|
| 79 |
P208 Contrast-enhanced ultrasound using intradermal microbubble sulfur hexafluoride for identification of sentinel lymph nodes during breast cancer surgery: a clinical trial
|
Materazzo, M.
|
|
|
68 |
S |
p. S98-S99
|
article
|
| 80 |
P032 Correlation of lymphocyte infiltration (TILs) in breast cancer with prognosis
|
Sanaat, Z.
|
|
|
68 |
S |
p. S28
|
article
|
| 81 |
P051 Cost-efficacy Analysis of Use of Frozen Section Histology for Margin Assessment During Breast Conservation Surgery in Breast Cancer Patients
|
Agarwal, G.
|
|
|
68 |
S |
p. S35
|
article
|
| 82 |
P052 Cox-2 overexpression in triple-negative invasive ductal breast cancer with correlation to clinicopathological parameters and neoangiogenesis
|
Volos, L.
|
|
|
68 |
S |
p. S35-S36
|
article
|
| 83 |
P265 Cryoablation in Breast Cancer Care - an analysis from a Single Multi-Disciplinary Unit in Southern Africa
|
Benn, C.
|
|
|
68 |
S |
p. S121
|
article
|
| 84 |
P266 Cryoablation with endocrine therapy for clinical stage I/II, ER+, HER2- invasive breast cancer in patients with omission of surgical axillary staging
|
Goldaracena, J.M. Oliver
|
|
|
68 |
S |
p. S121-S122
|
article
|
| 85 |
P091 Deep inspiration breath hold in post-operative radiotherapy for right breast cancer
|
Valli, M.
|
|
|
68 |
S |
p. S50
|
article
|
| 86 |
P250 Deep learning-based breast lesion localization and segmentation in 3d automated breast ultrasound (3d abus) images
|
Lertsatittanakron, S.
|
|
|
68 |
S |
p. S114-S115
|
article
|
| 87 |
P106 De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer: patterns of recurrence from a real-world single-centre cohort of patients
|
Banini, M.
|
|
|
68 |
S |
p. S55
|
article
|
| 88 |
P212 Development of a deep learning based model for guiding the dissection plane of robot endoscopy breast surgery
|
Lee, J.
|
|
|
68 |
S |
p. S100
|
article
|
| 89 |
P301 Diagnostic accuracy of Fine Needle Aspiration cytology of Breast masses, and Morphologic patterns of Breast lesions, Hawassa, Southern Ethiopia: A five year review
|
Alem, A.
|
|
|
68 |
S |
p. S135
|
article
|
| 90 |
P172 Different incidence of brain metastasis according to HER2 expression level in patients with triple negative breast cancer
|
Koi, Y.
|
|
|
68 |
S |
p. S83
|
article
|
| 91 |
P165 Distance from epicenter of tumor to nipple in predicting regional lymphnode metastasis
|
Chatmongkonwat, T.
|
|
|
68 |
S |
p. S79
|
article
|
| 92 |
P025 Distinguishing second primary tumor frommetastasis in bilateral breast cancer using clinicopathological correlation and whole exome sequencing-based clonal relatedness analyses
|
Chirappapha, P.
|
|
|
68 |
S |
p. S25-S26
|
article
|
| 93 |
P090 Dosimetric Evaluation of the Heart and Left Anterior Descending Artery Dose in Radiotherapy for Japanese patients with Breast Cancer
|
Tanaka, O.
|
|
|
68 |
S |
p. S50
|
article
|
| 94 |
P171 Do Tumor Infiltrating Lymphocytes and Programmed Cell Death Ligand -1 have a Predictive and Prognostic Role in Advanced Triple Negative Breast Cancers – Results of a Study from a Developing Country
|
Agarwal, G.
|
|
|
68 |
S |
p. S82-S83
|
article
|
| 95 |
P053 Dysregulation of microRNA signature in breast cancer cells can facilitate overexpression of genes responsible for multiple drug resistance
|
Halytskiy, V.
|
|
|
68 |
S |
p. S36
|
article
|
| 96 |
P038 Early detection of breast cancer in liquid biopsies using DNA methylation markers
|
Neefs, I.
|
|
|
68 |
S |
p. S30-S31
|
article
|
| 97 |
P219 Early experience with Magtrace ® for sentinel node biopsies in two Scottish breast cancer units
|
Williams, J.
|
|
|
68 |
S |
p. S103
|
article
|
| 98 |
P278 Early Integrated Rehabilitation Helped Breast Cancer Patients to Start Healthy Lifestyle– A Comparison Between the Intervention and Control Group in a Prospective Study
|
Borovcic, M. Kurir
|
|
|
68 |
S |
p. S127
|
article
|
| 99 |
P233 Early outcomes of volume replacement using injectable acellular dermal matrix for oncoplastic breast conserving surgery
|
Park, E.H.
|
|
|
68 |
S |
p. S108
|
article
|
| 100 |
P220 Early post-operative outcome of pre-pectoral implant-based immediate total breast reconstruction with Vicryl mesh - An experience from a low-middle income country
|
Virji, S.
|
|
|
68 |
S |
p. S103
|
article
|
| 101 |
P223 Effect of margins in recurrence rate following breast conserving therapy
|
Wang, L.
|
|
|
68 |
S |
p. S104-S105
|
article
|
| 102 |
P285 Effect of socio-demographic factors on patient reported outcomes in Indian breast cancer patients
|
Vartak, A.
|
|
|
68 |
S |
p. S129-S130
|
article
|
| 103 |
P127 Efficacy and safety of trastuzumab biosimilar Abdi Ibrahim in the neoadjuvant setting for HER2 positive breast cancer: about 40 cases
|
Nèche, N.
|
|
|
68 |
S |
p. S64
|
article
|
| 104 |
P118 Efficacy of platinum-based neoadjuvant chemotherapy in early triple-negative breast cancer according to germline BRCA mutation
|
Bae, S.J.
|
|
|
68 |
S |
p. S59-S60
|
article
|
| 105 |
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer
|
Hamida, K. Ben
|
|
|
68 |
S |
p. S30
|
article
|
| 106 |
P027 Establishment of a Thai patient-derived breast cancer organoid biobanking for drug screening in a single medical center in Thailand
|
Chirappapha, P.
|
|
|
68 |
S |
p. S27
|
article
|
| 107 |
P040 Estrogen-induced epigenetic regulation of matrisome-related genes in breast cancer
|
Hamad, M.
|
|
|
68 |
S |
p. S31
|
article
|
| 108 |
P041 Evaluation of an optimal cut point for the Ki-67 as a predictive recurrent marker of early-stage ER/PR positive and HER2 negative breast cancer
|
Ruangprasertkun, P.
|
|
|
68 |
S |
p. S31-S32
|
article
|
| 109 |
P138 Evaluation of germline mutation in high risk breast cancer cohort: compliance with NCCN 2023 v.1 testing criteria
|
Kwong, A.
|
|
|
68 |
S |
p. S68-S69
|
article
|
| 110 |
P107 Evaluation of Patient Satisfaction with Breast Q after Post-mastectomy Hypofractionated Radiotherapy with Immediate Implant Reconstruction
|
Erdogdu, S.
|
|
|
68 |
S |
p. S55-S56
|
article
|
| 111 |
P075 Evaluation of personality traits of breast cancer patients in the context of their surgical therapy
|
Tasgin, C.
|
|
|
68 |
S |
p. S43-S44
|
article
|
| 112 |
P248 Evaluation of potential factors related to chemotherapy-induced nausea and vomiting (CINV) among Chinese breast cancer patients: individual patient data analysis
|
Yeo, W.
|
|
|
68 |
S |
p. S114
|
article
|
| 113 |
P300 Evaluation of preoperative breast MRI findings in breast cancer patients
|
Syrgiannis, K.
|
|
|
68 |
S |
p. S135
|
article
|
| 114 |
P295 Evaluation of Sentinel Lymph Node by sonography
|
Hashimoto, T.
|
|
|
68 |
S |
p. S133
|
article
|
| 115 |
P291 Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers
|
Beltran-Bless, A.-A.
|
|
|
68 |
S |
p. S132
|
article
|
| 116 |
P155 Exploration of specific population for adjuvant capecitabine escalation therapy in early-stage triple-negative breast cancer: a retrospective biological sample analysis of the CBCSG010 clinical trial
|
Wu, W.
|
|
|
68 |
S |
p. S76
|
article
|
| 117 |
P209 Factors affecting drain indwelling time after axillary dissection in patients with breast cancer
|
Pantha, B.
|
|
|
68 |
S |
p. S99
|
article
|
| 118 |
P056 Factors associated with long-term prognosis in the nonmetastatic HER2-positive breast cancer. A nationwide study from Korean Breast Cancer Society
|
Kang, Y.-J.
|
|
|
68 |
S |
p. S37
|
article
|
| 119 |
P182 Factors Influencing Breast Cancer Resection Volumes and their Impact on Treatment Outcome: Multi-center Prospective Study (FIBRATIO) – Study Protocol and Preliminary Results
|
Karhunen-Enckell, U.
|
|
|
68 |
S |
p. S87-S88
|
article
|
| 120 |
P139 Factors influencing underutilization of genetic clinic services by surgeons and breast cancer patients in Low-Middle Income countries- A retrospective cross-sectional study
|
Jabeen, D.
|
|
|
68 |
S |
p. S69
|
article
|
| 121 |
P083 Factors relating to locally advanced breast cancer in rural areas
|
Kuntaraksa, N.
|
|
|
68 |
S |
p. S46-S47
|
article
|
| 122 |
P080 Fertility Preservation and Pregnancy in Breast Cancer Patients in Clinical Practice, Slovak Republic Survey
|
Mrinakova, B.
|
|
|
68 |
S |
p. S45
|
article
|
| 123 |
P063 First pilot breast screening project in Armenia
|
Avetisyan, A.
|
|
|
68 |
S |
p. S39-S40
|
article
|
| 124 |
P050 Functional characterization of genomic variants of uncertain significance (VUS) in the ATM gene
|
Yilmaz, S. Ustun
|
|
|
68 |
S |
p. S34-S35
|
article
|
| 125 |
P142 Functional impact of a rare germline TP53 variant (NM_001126114.2, c.1018A>G, p.N340D) in a family with the Li-Fraumeni-like syndrome
|
Olivier, D.W.
|
|
|
68 |
S |
p. S70
|
article
|
| 126 |
P170 HER2-low expression is associated with better prognosis in patients with early breast cancer: A systematic review and meta-analysis
|
Wei, T.
|
|
|
68 |
S |
p. S82
|
article
|
| 127 |
P065 High satisfaction of women in Slovenian breast cancer screening program DORA: results of an anonymous survey
|
Borovčić, M. Kurir
|
|
|
68 |
S |
p. S40-S41
|
article
|
| 128 |
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?
|
Zhao, R.
|
|
|
68 |
S |
p. S128
|
article
|
| 129 |
P262 How patients prioritize features of different potential treatment pathways in early breast cancer: a best-worst scaling study
|
Jackisch, C.
|
|
|
68 |
S |
p. S119-S120
|
article
|
| 130 |
P097 Hypofractionated radiotherapy after neoadjuvant chemotherapy in Breast Cancer: Safety, feasibility, and early outcomes
|
Abdessatar, G.
|
|
|
68 |
S |
p. S52
|
article
|
| 131 |
P094 Hypo-fractionated radiotherapy in early breast cancer patients – Local control, long term results
|
Grigoropoulos, P.
|
|
|
68 |
S |
p. S51
|
article
|
| 132 |
P104 Hypofractionated radiotherapy in triple negative breast cancer: Does molecular subtype impact radiotherapy outcomes ?
|
Skouri, M.
|
|
|
68 |
S |
p. S54-S55
|
article
|
| 133 |
P198 Identification of sentinel lymph nodes using the near infrared light camera system LIGHTVISION®
|
Iwamoto, M.
|
|
|
68 |
S |
p. S94
|
article
|
| 134 |
P236 Immediate breast reconstruction as a day case procedure and impact of COVID-19 pandemic
|
Garg, N.
|
|
|
68 |
S |
p. S109
|
article
|
| 135 |
P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
|
Mitova, V.
|
|
|
68 |
S |
p. S118
|
article
|
| 136 |
P148 Immunohistochemical expression of cancer stem cell markers in breast carcinoma patients of pakistan
|
Ali, S.M.A.
|
|
|
68 |
S |
p. S73
|
article
|
| 137 |
P133 Immunohistochemical expression of estrogen receptors after neoadjuvant chemotherapy in breast cancer
|
Hamida, K. Ben
|
|
|
68 |
S |
p. S66-S67
|
article
|
| 138 |
P189 Impact assessment of sentinel lymph node core needle biopsy guided by ultrasound for node-positive breast cancer patients
|
Kinoglou, G.
|
|
|
68 |
S |
p. S90
|
article
|
| 139 |
P093 Impact of breast size on partial breast radiotherapy planning and short term outcome: a single institution experience at University Hospital of North Midlands (UHNM) UK
|
Gilani, S.
|
|
|
68 |
S |
p. S50
|
article
|
| 140 |
P249 IMPACT of COVID-19 pandemic on breast cancer diagnosis and treatment
|
Ranchor, R.
|
|
|
68 |
S |
p. S114
|
article
|
| 141 |
P257 Impact of electronic Patient Reported Outcomes for symptom monitoring on unplanned consultations and hospitalizations in cancer patients receiving systemic therapy
|
Kühne, C.
|
|
|
68 |
S |
p. S117
|
article
|
| 142 |
P225 Impact Of Oncoplasty in Increasing Breast Conservation Rates Post Neo-Adjuvant Chemotherapy
|
Koppiker, C.B
|
|
|
68 |
S |
p. S105
|
article
|
| 143 |
P005 Impact of oral bacterial counts on febrile neutropenia during breast cancer chemotherapy
|
Suzuki, K.
|
|
|
68 |
S |
p. S17
|
article
|
| 144 |
P089 Impact of radiation on immediate breast reconstruction: A retrospective single institution cohort study
|
Saksornchai, K.
|
|
|
68 |
S |
p. S49-S50
|
article
|
| 145 |
P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
|
Hoefnagels, N.
|
|
|
68 |
S |
p. S122-S123
|
article
|
| 146 |
P136 Improving incentives to BRCA testing through amending health insurance regulation – a critical analysis
|
Chan, W.
|
|
|
68 |
S |
p. S67
|
article
|
| 147 |
P013 Inadequate ovarian suppression in premenopausal estrogen receptor breast cancer patients on ovarian suppression therapy
|
Chen, D.-R.
|
|
|
68 |
S |
p. S20
|
article
|
| 148 |
P226 Indocyanine green fluorescence imaging for real-time detection of breast cancer tumors: a systematic review
|
Pop, C.F.
|
|
|
68 |
S |
p. S106
|
article
|
| 149 |
P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib
|
Bartsch, R.
|
|
|
68 |
S |
p. S20-S21
|
article
|
| 150 |
P105 Internal mammary chain irradiation in breast cancer patients: Which patterns of practice between controversial benefit and challenging dosimetry?
|
Naimi, Z.
|
|
|
68 |
S |
p. S55
|
article
|
| 151 |
P193 Intraoperative specimen digital breast tomosynthesis as predictor of resection margin status in breast conserving surgery for breast cancer - first year experience
|
Pavlišta, D.
|
|
|
68 |
S |
p. S92
|
article
|
| 152 |
P128 Intraoperative Ultrasound Guided Tailored Axillary Surgery After Neoadjuvant Therapy in Breast Cancer Patients
|
Balbaloglu, H.
|
|
|
68 |
S |
p. S65
|
article
|
| 153 |
P073 Invasive lobular breast cancer: a one- or two-sided problem (preliminary results)
|
Van den Bosch, L.
|
|
|
68 |
S |
p. S43
|
article
|
| 154 |
P049 Investigating the pathogenesis of poor-outcome Triple-Negative Breast Cancer
|
Angel, C.Z.
|
|
|
68 |
S |
p. S34
|
article
|
| 155 |
P238 Is BCT safer than Mastectomy for the treatment of early breast cancer?
|
Mele, M.
|
|
|
68 |
S |
p. S110
|
article
|
| 156 |
P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)?
|
Calamac, M.
|
|
|
68 |
S |
p. S130-S131
|
article
|
| 157 |
P176 Is the ≥1-cm width of resection margin in phyllodes tumor necessary to reduce recurrence?
|
Changchit, N.
|
|
|
68 |
S |
p. S85
|
article
|
| 158 |
P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
|
Wimmer, K.
|
|
|
68 |
S |
p. S123-S124
|
article
|
| 159 |
P243 Is the indian population ready for acosog z0011 protocol?
|
Nadarajan, A.R.
|
|
|
68 |
S |
p. S112
|
article
|
| 160 |
P143 Kinetics of Ejection Fraction Decline as A Predictive Factor for Cardiotoxicity in Trastuzumab-treated Early Breast Cancer Patients: Single Institution Experience
|
Korani, O.M.
|
|
|
68 |
S |
p. S70-S71
|
article
|
| 161 |
P034 KLK4 in luminal breast cancer progression
|
Fuentes, P.
|
|
|
68 |
S |
p. S29
|
article
|
| 162 |
P068 Knowledge Translation for Implementation of Point-of-Care Technology (POCT) in Breast Cancer Survivors in Africa: Descriptive study
|
Milambo, J.P.M.
|
|
|
68 |
S |
p. S41
|
article
|
| 163 |
P030 Leverage of microenvironmental Ornithine in Triple Negative Breast Cancer Cells under Glutamine Starvation
|
Verch, G.
|
|
|
68 |
S |
p. S28
|
article
|
| 164 |
P290 Life without a breast : The underreported symptoms after radical mastectomy
|
Mezghani, M.
|
|
|
68 |
S |
p. S131
|
article
|
| 165 |
P185 Long-term impact of radiotherapy on the clinical and patient-reported outcomes of immediate breast reconstruction in a UK population-based cohort study
|
Johnson, L.
|
|
|
68 |
S |
p. S89
|
article
|
| 166 |
P076 Long-term outcome after omission of open surgical resection of B3-lesions of the breast
|
Schrading, S.
|
|
|
68 |
S |
p. S44
|
article
|
| 167 |
P181 Lymphedema after axillary dissection: Is there a room for calcium dobesilate in treatment?
|
Yildiz, A.
|
|
|
68 |
S |
p. S87
|
article
|
| 168 |
P023 Male breast cancer: a single center report of histopathological sybtypes and outcomes
|
Mrinakova, B.
|
|
|
68 |
S |
p. S25
|
article
|
| 169 |
P157 MammaPrint 8-year follow up results in patients with early breast cancer from a single-center Italian cohort study
|
Fiorino, E.
|
|
|
68 |
S |
p. S76-S77
|
article
|
| 170 |
P199 Management and Outcomes of Very Young Women (≤35 Years) with Breast Cancer treated in a single Institution
|
Scardina, L.
|
|
|
68 |
S |
p. S94
|
article
|
| 171 |
P272 Manual lymph drainage does not substantially improve the effect of decongestive lymphatic therapy in people with breast cancer-related lymphoedema (EFforT-BCRL trial): a multicentre randomised trial
|
De Vrieze, T.
|
|
|
68 |
S |
p. S124-S125
|
article
|
| 172 |
P140 Menopausal breast cancer: Bone Mineral Density (BMD) and prognostic factors
|
Izquierdo, M.
|
|
|
68 |
S |
p. S69-S70
|
article
|
| 173 |
P042 MicroRNA signature abnormalities in breast cancer cells can facilitate overexpression of chemokines and their receptors responsible for recruitment of stromal cells into tumor microenvironment
|
Halytskiy, V.
|
|
|
68 |
S |
p. S32
|
article
|
| 174 |
P205 Modified pectoral nerve block conducted Intraoperatively by surgeons Is effective for postmastectomy pain control: A prospective double-blinded randomized control trial
|
Imruetaicharoenchoke, W.
|
|
|
68 |
S |
p. S97
|
article
|
| 175 |
P054 Molecular characterization and the role of lymphocyte microenvironment in breast cancer
|
Hamida, K. Ben
|
|
|
68 |
S |
p. S36
|
article
|
| 176 |
P055 Morphological features of tumor angiogenesis in invasive ductal breast cancer and relationship with clinicopathological factors
|
Volos, L.
|
|
|
68 |
S |
p. S36-S37
|
article
|
| 177 |
P113 MRI Patterns in the evaluation of pathological response after Neoadjuvant Endocrine therapy in ER+/HER2- Breast Cancer and Implications on Surgical Planning
|
Nakad, B.
|
|
|
68 |
S |
p. S57-S58
|
article
|
| 178 |
P239 Multi-institutional Experience of Modified Lateral Intercostal Artery Perforator (LICAP) Flap Operation: Surgical and Patient Reported Outcomes (PROMs)
|
Sallam, I.
|
|
|
68 |
S |
p. S110
|
article
|
| 179 |
P163 Mutation profiling of NOTCH signaling pathway in primary breast cancer among Indian population
|
Tanwar, P.
|
|
|
68 |
S |
p. S78
|
article
|
| 180 |
P129 Neoadjuvant chemotherapy in ER-positive Early Breast Cancer: predictive factors of response and outcome
|
Kouadri, N.
|
|
|
68 |
S |
p. S65
|
article
|
| 181 |
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
|
Kümmel, S.
|
|
|
68 |
S |
p. S63-S64
|
article
|
| 182 |
P134 Neoadjuvant Therapy in Non-Metastatic Breast Cancer in Kurdistan, Iraq
|
Namiq, K.
|
|
|
68 |
S |
p. S67
|
article
|
| 183 |
P159 Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio are not predictive of Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
|
de Pinho, I. Soares
|
|
|
68 |
S |
p. S77
|
article
|
| 184 |
P115 OlympiaN: a phase 2, multicenter, open-label study to assess the efficacy and safety of neoadjuvant olaparib with or without durvalumab in patients with BRCAm early-stage HER2-negative breast cancer
|
Balmaña, J.
|
|
|
68 |
S |
p. S58
|
article
|
| 185 |
P254 Omani Undergraduate Nursing Student’s Perception of Training Programs and Knowledge on Palliative Care: A Nationwide Survey
|
Lazarus, E.R.
|
|
|
68 |
S |
p. S116
|
article
|
| 186 |
P168 OncotypeDX RS new TAILORx cut-offs: omitting Chemotherapy in more patients aged >50 years with Early Breast Cancer
|
MarKopoulos, C.
|
|
|
68 |
S |
p. S81
|
article
|
| 187 |
P123 Optimal Regimen of Neoadjuvant Systemic Therapy for HER2 Positive Early Breast Cancer
|
Lo, C.
|
|
|
68 |
S |
p. S61-S62
|
article
|
| 188 |
P058 Outcomes of Rural Men With Breast Cancer: A Multicenter Population Based Retrospective Cohort Study
|
Fisher, L.
|
|
|
68 |
S |
p. S38
|
article
|
| 189 |
P287 Overall survival after neoadjuvant chemotherapy depending on pathological response and tumoral phenotype
|
Gortari, M. Ciaurriz
|
|
|
68 |
S |
p. S130
|
article
|
| 190 |
P283 Overall survival of patients treated for breast cancer: about 124 cases
|
Benzebida, H.
|
|
|
68 |
S |
p. S129
|
article
|
| 191 |
P126 Pathological complete response after neoadjuvant chemotherapy in patients with HER2 low and HER2 0 early breast cancer (eBC) – experience from Institute for Oncology and Radiology of Serbia (IORS)
|
Djurmez, O.
|
|
|
68 |
S |
p. S64
|
article
|
| 192 |
P016 Patient Characteristics, Treatment and Long-term Outcomes from a Real-World Population of Early Breast Cancer Patients at High risk of Recurrence in Scotland
|
Hall, P.S.
|
|
|
68 |
S |
p. S21-S22
|
article
|
| 193 |
P201 Patient reported outcome measures in patients who have undergone chest wall perforator flaps (cwpfs) for breast recostruction
|
Laroiya, I.
|
|
|
68 |
S |
p. S95
|
article
|
| 194 |
P276 Patients’ Expectations for Follow-Up of Early Breast Cancer: A Cross-Sectional Study
|
Papadopoulos, L.
|
|
|
68 |
S |
p. S125-S126
|
article
|
| 195 |
P263 Patients’ perspectives on treatments for HR+/HER2– early breast cancer: developing a quantitative patient preference survey
|
Harmer, V.
|
|
|
68 |
S |
p. S120
|
article
|
| 196 |
P267 Percutaneous cryoablation treatment of early and low risk breast cancer. An effective alternative to surgical treatment
|
Navarro, M.J. Roca
|
|
|
68 |
S |
p. S122
|
article
|
| 197 |
P218 Perforator Flaps: Can they be an elixir for the oncoplasty woes of developing nations?
|
Koppiker, C.B
|
|
|
68 |
S |
p. S102-S103
|
article
|
| 198 |
P137 PERSONA study: Optimization of the value-based healthcare as for the follow-up of women with breast cancer- A portrait of breast cancer survivor’s follow-up in Portugal
|
Bandarra, M.M. Costa Ferreira
|
|
|
68 |
S |
p. S67-S68
|
article
|
| 199 |
P158 PONDx Aragon: First spanish prospective study evaluating the impact of the 21-gene test on real praxis for N1 patients after RxPONDER results
|
Andres, R.
|
|
|
68 |
S |
p. S77
|
article
|
| 200 |
P099 Postoperative cosmetic outcome of intraoperative radiotherapy in comparison to whole breast radiotherapy in early stage breast cancer; A retrospective cohort study
|
Nafissi, N.
|
|
|
68 |
S |
p. S52-S53
|
article
|
| 201 |
P207 Postoperative outcomes of replacement technique using the acellular dermal matrix as filler for BCS patients
|
Park, J.T.
|
|
|
68 |
S |
p. S98
|
article
|
| 202 |
P145 Postpartum breast cancer diagnosed within 10 years of last childbirth is a prognostic factor for distant metastasis – analysis of lymphovascular invasion relating factors
|
Iesato, A.
|
|
|
68 |
S |
p. S71
|
article
|
| 203 |
P103 PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification
|
Rattay, T.
|
|
|
68 |
S |
p. S54
|
article
|
| 204 |
P167 Prediction of Axillary lymph node metastasis by Tumor to breast ratio in breast cancer
|
Phool, W.
|
|
|
68 |
S |
p. S80
|
article
|
| 205 |
P294 Prediction of tumor microenvironment functionality using 18Ffluorodeoxyglucose Positron Emission Tomography/computed Tomography for early-stage triple negative breast cancer
|
Kimura, Y.
|
|
|
68 |
S |
p. S133
|
article
|
| 206 |
P031 Preoperative mammocartography and mammometry for the needs of oncoplastic approaches
|
Ilieva, I.
|
|
|
68 |
S |
p. S28
|
article
|
| 207 |
P177 Prepectoral versus subpectoral implant-based breast reconstruction: A systemic review and meta-analysis
|
Ostapenko, E.
|
|
|
68 |
S |
p. S86
|
article
|
| 208 |
P231 Prepectoral versus subpectoral single stage breast reconstruction after conservative mastectomy for breast cancer: surgical and oncological outcomes
|
Scardina, L.
|
|
|
68 |
S |
p. S107-S108
|
article
|
| 209 |
P121 Primary Chemotherapy with Bevacizumab for Locally Advanced Triple Negative Breast Cancer
|
Carpenter, J.
|
|
|
68 |
S |
p. S61
|
article
|
| 210 |
P141 Prognostic factors breast cancer after pregnancy
|
Izquierdo, M.
|
|
|
68 |
S |
p. S70
|
article
|
| 211 |
P020 Prognostic impact of adjuvant therapy after radical resection for loco-regional recurrence of breast cancer
|
. 羽山,
|
|
|
68 |
S |
p. S24
|
article
|
| 212 |
P149 Prognostic impact of egfr, cox2 and p53 expression on breast carcinoma patients from high-risk population of pakistan
|
Adnan, Y.
|
|
|
68 |
S |
p. S73
|
article
|
| 213 |
P304 Prognostic significance of ki-67 expression in Breast Cancer Patient
|
Urooj, N.
|
|
|
68 |
S |
p. S85
|
article
|
| 214 |
P195 Prophylactic Risk Reducing Mastectomy (PRRM): A set practice or catch 22 in low middle income countries. A single-center prospective cohort study
|
Vohra, L.
|
|
|
68 |
S |
p. S92-S93
|
article
|
| 215 |
P227 Prospective Randomized controlled trial evaluation safety of Breast conserving surgery in multicentric/multifocal breast cancer
|
Urooj, N.
|
|
|
68 |
S |
p. S106
|
article
|
| 216 |
P150 Psychological distress during hospitalization for breast cancer patients in the outbreak, post-peak, and normalization stages of the COVID-19 pandemic
|
Zhao, X.
|
|
|
68 |
S |
p. S73-S74
|
article
|
| 217 |
P192 Ptotic versus non ptotic breasts in nipple-sparing mastectomy and immediate prepectoral breast reconstruction
|
Ostapenko, E.
|
|
|
68 |
S |
p. S91-S92
|
article
|
| 218 |
P206 Pushing the iımits of breast conservation therapy with extreme oncoplasty
|
Kılıç, B.
|
|
|
68 |
S |
p. S97
|
article
|
| 219 |
P004 Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trial
|
Cao, F.
|
|
|
68 |
S |
p. S16
|
article
|
| 220 |
P286 Quadruple Negative Breast Cancer (QNBC): outcomes in survival and comparison with the classic phenotype of TNBC
|
Koura, S.
|
|
|
68 |
S |
p. S130
|
article
|
| 221 |
P224 Quality of life and patient outcomes after oncoplastic breast conservation versus nipple sparing mastectomy and immediate breast reconstruction
|
Angelidou, E.
|
|
|
68 |
S |
p. S105
|
article
|
| 222 |
P256 Quality of life in breast cancer patients, preoperatively and postoperatively. Methods of influencing the quality of life. M. M. Valcan university of oradea, faculty of medicine and pharmacy, romania
|
Valcan, M.M.
|
|
|
68 |
S |
p. S117
|
article
|
| 223 |
P045 Quantification of plasma extracellular vesicles in breast cancer patients by Single Molecule Array
|
Favilla, K.
|
|
|
68 |
S |
p. S33
|
article
|
| 224 |
P092 Radiation induced hypothyroidism in breast cancer
|
Acharya, S.
|
|
|
68 |
S |
p. S50
|
article
|
| 225 |
P247 Radiofrequency as a method of localizing occult breast lesions
|
Malik, M.
|
|
|
68 |
S |
p. S113-S114
|
article
|
| 226 |
P210 Radiological and pathological predictors of post-operative upstaging to invasive ductal carcinoma and lymph nodes metastasis in patients preoperatively diagnosed with breast ductal carcinoma in situ
|
Pellicciaro, M.
|
|
|
68 |
S |
p. S99
|
article
|
| 227 |
P006 Randomized Phase II trial evaluating three anti-diarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)
|
González-Santiago, S.
|
|
|
68 |
S |
p. S17
|
article
|
| 228 |
P077 Rapid Point of Care Germline Genetic Testing Pathway with Increased Eligibility Criteria in a Large Integrated Health Care System
|
Shim, V.
|
|
|
68 |
S |
p. S44-S45
|
article
|
| 229 |
P244 Rates of lymphoedema and complications using a vessel sealing device in axillary node clearance compared to standard technique in a single tertiary centre
|
Wignarajah, P.
|
|
|
68 |
S |
p. S112-S113
|
article
|
| 230 |
P008 Real-world analysis of the clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage node positive breast cancer in Ireland
|
Browne, I.M.
|
|
|
68 |
S |
p. S18
|
article
|
| 231 |
P260 Real World Data Analysis of Palbociclib plus endocrine therapy in first-line in ibero-american premenopausal women with Luminal Advanced Breast Cancer
|
Samame, J.C.
|
|
|
68 |
S |
p. S118
|
article
|
| 232 |
P131 Real World Evidence of the Impact at Neoadjuvant Chemotherapy Treatment on the Prognosis of Patients with Early Breast Cancer
|
Antonini, M.
|
|
|
68 |
S |
p. S66
|
article
|
| 233 |
P082 Real-World Experience with CDK4/6 Inhibitors for Metastatic HR +/HER2− Breast Cancer at a Single Cancer Center
|
Kovacevic, M. Milovic
|
|
|
68 |
S |
p. S46
|
article
|
| 234 |
P251 Real-world experience with CDK4/6 inhibitors for metastatic HR+/HER2−breast cancer at a single cancer center
|
Milovic - Kovacevic, M.
|
|
|
68 |
S |
p. S115
|
article
|
| 235 |
P269 Real world experience with Everolimus in the management of metastatic breast cancer ER positive/HER2 negative
|
Reyes, A. Garcilazo
|
|
|
68 |
S |
p. S123
|
article
|
| 236 |
P130 Recurrence rate following pCR in patients receiving NACT
|
Raniwala, A.
|
|
|
68 |
S |
p. S65-S66
|
article
|
| 237 |
P119 Recurrence Score® result by the 21-gene assay before and after systemic neoadjuvant chemotherapy in patients with HR+ HER2-breast cancer.
|
Ciriaco, N.
|
|
|
68 |
S |
p. S60
|
article
|
| 238 |
P057 Relationship between TP53 mutations and mammographic and ultrasonographic findings in breast cancer
|
Lee, S.
|
|
|
68 |
S |
p. S37-S38
|
article
|
| 239 |
P135 Response to neoadjuvant chemotherapy in HER2-positive breast cancers: a single-centre study
|
Hamida, K. Ben
|
|
|
68 |
S |
p. S67
|
article
|
| 240 |
P010 Retrospective modeling of adherence to endocrine therapy in early breast cancer using real-world claims data
|
Dannehl, D.
|
|
|
68 |
S |
p. S19
|
article
|
| 241 |
P289 Retrospective study of pregnancy outcome after breast cancer
|
Yoshimura, A.
|
|
|
68 |
S |
p. S131
|
article
|
| 242 |
P261 Review of mammogram-led follow-up outcomes in Early Breast Cancer patients
|
Khan, S.A.
|
|
|
68 |
S |
p. S118-S119
|
article
|
| 243 |
P146 Risk factors of breast cancer recurrence in pathologic complete response achieved patients following neoadjuvant chemotherapy
|
Choi, J.Y.
|
|
|
68 |
S |
p. S72
|
article
|
| 244 |
P064 Risk-reducing mastectomy in ovarian cancer patients with BRCA1/2 pathogenic variants: a comprehensive review
|
Bonci, E.-A.
|
|
|
68 |
S |
p. S40
|
article
|
| 245 |
P174 Role of Age on Biomarker Status and Clinical Feature in Early Breast Cancer at Dr. Saiful Anwar Hospital, Malang- Indonesia
|
Wardhani, S.O.
|
|
|
68 |
S |
p. S83-S84
|
article
|
| 246 |
P003 ROSE trial: A prospective non-interventional study to assess the quality of life (QoL) of premenopausal patients with early breast cancer receiving triptorelin as ovarian function suppression
|
Mauri, G.
|
|
|
68 |
S |
p. S15-S16
|
article
|
| 247 |
P001 Scalp cooling system for breast cancer patients treated by adjuvant or neo-adjuvant chemotherapy
|
Hosoda, M.
|
|
|
68 |
S |
p. S15
|
article
|
| 248 |
P200 Sentinel lymph node biopsy in the elderly breast cancer patient – 10 year experience from a Swiss tertiary center
|
Heidinger, M.
|
|
|
68 |
S |
p. S94-S95
|
article
|
| 249 |
P173 Should positive surgical margin involvement of in situ carcinoma of invasive breast cancer after breast conserving surgery be treated with additional resection?
|
Yoshii, Y.
|
|
|
68 |
S |
p. S83
|
article
|
| 250 |
P108 Should we delineate brachial plexus in hypofractionated locoregional breast radiotherapy to reduce the risk of brachial plexopathy?
|
Moujahed, R.
|
|
|
68 |
S |
p. S56
|
article
|
| 251 |
P277 Sick leave and predictive factors for sick leave at 12 months after breast cancer surgery in the randomized controlled physical activity trial (PhysSURG-B)
|
Heiman, J.
|
|
|
68 |
S |
p. S126-S127
|
article
|
| 252 |
P194 Single-incision endoscope-assisted breast-conserving surgery and sentinel lymph node biopsy: A prospective cohort study (the SINA-BCS study)
|
Lu, S.
|
|
|
68 |
S |
p. S92
|
article
|
| 253 |
P241 Skin reducing mastectomy and immediate hybrid breast reconstruction using combination of acellular pericardium matrix and deepithelialized dermal flap in patients with hypertrophic and ptotic breasts
|
Varvaras, D.
|
|
|
68 |
S |
p. S111
|
article
|
| 254 |
P191 Skin-sparing or nipple-sparing mastectomy with one-stage or two-stage reconstruction: analysis of early outcomes and patient’s satisfaction
|
Gurrado, A.
|
|
|
68 |
S |
p. S91
|
article
|
| 255 |
P035 SLC26A9 promotes the development and stemness of triple-negative breast cancer via activating EGFR/PI3 K/AKT signaling pathway
|
Zhou, Z.
|
|
|
68 |
S |
p. S29-S30
|
article
|
| 256 |
P072 18-SNP polygenic risk score does not improve breast cancer risk prediction in women aged 40–49 years in a Central European population with breast cancer risk below European average
|
Oblak, T.
|
|
|
68 |
S |
p. S42-S43
|
article
|
| 257 |
P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings
|
Hall, P.
|
|
|
68 |
S |
p. S47
|
article
|
| 258 |
P204 SPECT/CT lymphoscintigraphy can accurately localize the sentinel lymph nodes and the clipped node in breast cancer patients undergoing targeted axillary dissection after neoadjuvant chemotherapy
|
Dilege, E.
|
|
|
68 |
S |
p. S97
|
article
|
| 259 |
P211 Surgical treatment for elderly patients with ductal carcinoma in situ. Is it still a safety and valid option?
|
Pellicciaro, M.
|
|
|
68 |
S |
p. S99-S100
|
article
|
| 260 |
P282 Survival outcomes after neoadjuvant chemotherapy according to the axillary status and tumor subtype
|
López-Marín, L.
|
|
|
68 |
S |
p. S128
|
article
|
| 261 |
P012 Survival outcomes and toxicities of adjuvant docetaxel-cyclophosphamide for four cycles in node negative triple negative and HER2 positive Chinese breast cancer patients: A 10 year follow up study
|
Wong, H.C.Y.
|
|
|
68 |
S |
p. S19-S20
|
article
|
| 262 |
P026 Synchronous and metachronous bilateral breast cancers: explanation of clinical differences in terms of lead-time bias and late detection
|
Chirappapha, P.
|
|
|
68 |
S |
p. S26-S27
|
article
|
| 263 |
P222 Systemic inflammation markers as predictors of axillary clearance: a multicenter analysis on 1274 nodal positive breast cancer patients undergoing primary systemic treatment
|
Gasparri, M.L.
|
|
|
68 |
S |
p. S104
|
article
|
| 264 |
P007 Tamoxifen reduced breast cancer recurrence in women with DCIS who underwent mastectomy
|
Saesim, N.
|
|
|
68 |
S |
p. S17-S18
|
article
|
| 265 |
P085 Target axillary disecction in cN2 breast cancer patients after neoadjuvant chemotherapy. Preliminary results
|
Castilla, M.
|
|
|
68 |
S |
p. S48
|
article
|
| 266 |
P202 Targeted axillary dissection after neoadjuvant chemotherapy: a multicenter prospective study of feasibility and safety
|
Villasco, A.
|
|
|
68 |
S |
p. S95-S96
|
article
|
| 267 |
P228 Targeted Axillary Dissection post primary chemotherapy: data analysis from a single multidisciplinary unit in South Africa
|
Benn, C.-A.
|
|
|
68 |
S |
p. S106-S107
|
article
|
| 268 |
P071 Telehealth in oncofertility and Breast Cancer Patients during COVID-19: Preliminary Results of Insenoallasalute.it project
|
Vanni, G.
|
|
|
68 |
S |
p. S42
|
article
|
| 269 |
P188 The accuracy of the upstaging prediction model for ductal carcinoma in situ: a retrospective comparative study
|
Chiu, C.-W.
|
|
|
68 |
S |
p. S90
|
article
|
| 270 |
P153 The clinical impact of Prosigna ® assay for adjuvant treatment in early-stage Thai breast cancer patients: single centre, real-life practice
|
Polchai, N.
|
|
|
68 |
S |
p. S75
|
article
|
| 271 |
P264 The Comparison Outcome of Implant-based Breast Reconstruction with ADM, Non-ADM and TiLOOP Reconstruction in Breast Cancer Patients: A Case Series
|
Arjhan, W.
|
|
|
68 |
S |
p. S120-S121
|
article
|
| 272 |
P281 The effect of Chinese culture on family planning of Childbearing age women with breast cancer in North China
|
Guo, J.
|
|
|
68 |
S |
p. S128
|
article
|
| 273 |
P067 The effect of COVID-19 pandemic on the use of Vacuum Assisted Breast Biopsy: An opportunity for change in Greece?
|
Matiatou, M.
|
|
|
68 |
S |
p. S41
|
article
|
| 274 |
P144 The Effect of Progesterone Receptor Expression Level to Predict Prognosis of Estrogen Receptor Positive/ HER2 Negative Young Breast Cancer: A Single-Center Prospective Cohort Study
|
Kwak, Y.
|
|
|
68 |
S |
p. S71
|
article
|
| 275 |
P088 The evaluation of the 21-gene Breast Recurrence Score assay as a prognostic factor for locoregional recurrence in early breast cancer treated by lumpectomy and intraoperative radiotherapy only
|
Leviov, M.
|
|
|
68 |
S |
p. S49
|
article
|
| 276 |
P213 The impact of chemotherapy on prepectoral breast reconstruction
|
Palli, D.
|
|
|
68 |
S |
p. S100
|
article
|
| 277 |
P271 The impact of extraordinary situations such as war on tumor characteristics and time before the start of treatment in patients with non-metastatic breast cancer (BC)
|
Martyniuk, O.
|
|
|
68 |
S |
p. S124
|
article
|
| 278 |
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience
|
Nasikas, D.
|
|
|
68 |
S |
p. S75
|
article
|
| 279 |
P302 The link between IL-6 rs1800797 and STAT3 rs4796793 Polymorphisms with breast cancer susceptibility in Bangladeshi women
|
Islam, M.S.
|
|
|
68 |
S |
p. S135
|
article
|
| 280 |
P273 The lived experiences of telehealth system use among women with breast cancer
|
Mohamad, N.B.Z.
|
|
|
68 |
S |
p. S125
|
article
|
| 281 |
P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer
|
Song, R.
|
|
|
68 |
S |
p. S74-S75
|
article
|
| 282 |
P110 The predictive role of SHARP1 and SHARP2 transcription factors in patients with breast cancer upon neoadjuvan chemotherapy
|
Ozdemir, K.
|
|
|
68 |
S |
p. S56-S57
|
article
|
| 283 |
P087 Therapeutic comparison of two oral chemothrapy regiments indicated in advanced breast cancer (Multicenter study of 74 cases)
|
Bouguettaya, A.
|
|
|
68 |
S |
p. S49
|
article
|
| 284 |
P216 Therapeutic Mammoplasty: Assures conservation, Elevates lifestyle. Data from the largest Asian cohort
|
Koppiker, C.B
|
|
|
68 |
S |
p. S102
|
article
|
| 285 |
P284 The relation of individual psychological traits and coping strategies to depression and anxiety levels among non-metastatic breast cancer patients
|
Karveli, S.
|
|
|
68 |
S |
p. S129
|
article
|
| 286 |
P022 The Relationship Between Trauma, Cancer C and Breast Cancer
|
Menang, J.
|
|
|
68 |
S |
p. S25
|
article
|
| 287 |
P214 The role of locoregional treatment in non-progressive de novo multi-metastatic breast cancer, a randomized controlled trial
|
Omranipour, R.
|
|
|
68 |
S |
p. S101
|
article
|
| 288 |
P234 The role of sentinel lymph node biopsy in the older patient with breast cancer- a single centre cohort study
|
Merh, R.
|
|
|
68 |
S |
p. S108
|
article
|
| 289 |
P124 The Study of subtype conversion after neoadjuvant chemotherapy in locally advance breast cancer
|
Virojanapa, K.
|
|
|
68 |
S |
p. S62-S63
|
article
|
| 290 |
P161 The updated PREDICT breast cancer prognostication in 91, 182 patients using Korean Breast Cancer Registry Data
|
Lee, J.
|
|
|
68 |
S |
p. S78
|
article
|
| 291 |
P235 The value of palpation, US and NMR in staging of axilla in patients with breast cancer in order to avoid unnecessery ALND
|
Maksimovic, Z.
|
|
|
68 |
S |
p. S108-S109
|
article
|
| 292 |
P079 The 5-year Survival of Breast Cancer patients from 2011–2015: The Medical City Experience
|
Tañeca, J.F.
|
|
|
68 |
S |
p. S45
|
article
|
| 293 |
P100 Thyroid dose distribution during hypofractionated radiotherapy for breast cancer
|
Rejeb, M. Ben
|
|
|
68 |
S |
p. S53
|
article
|
| 294 |
P132 (Trial in Progress) A phase 2, open-label, randomized multicenter trial to evaluate neoadjuvant lasofoxifene in molecularly-selected HR+/HER2− Clinical Stage 2/3 breast cancer
|
Chien, J.
|
|
|
68 |
S |
p. S66
|
article
|
| 295 |
P018 TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) ± durvalumab vs investigator’s choice of therapy (ICT) for triple-negative breast cancer (TNBC) with residual disease following neoadjuvant therapy
|
Bardia, A.
|
|
|
68 |
S |
p. S23
|
article
|
| 296 |
P095 Ultra-hypofractionated adjuvant radiotherapy in very elderly ratients with early breast cancer
|
Grigoropoulos, P.
|
|
|
68 |
S |
p. S51
|
article
|
| 297 |
P102 Ultra hypofractionated radiotherapy after breast conservative surgery : analysis of acute skin toxicity
|
Rejeb, M. Ben
|
|
|
68 |
S |
p. S54
|
article
|
| 298 |
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery
|
de Oliveira-Junior, I.
|
|
|
68 |
S |
p. S88-S89
|
article
|
| 299 |
P217 Upstaging and lymph node metastasis rate in patients with ductal carcinoma in situ who received mastectomy regarding the necessary of sentinel lymph node biopsy
|
Jang, J.
|
|
|
68 |
S |
p. S102
|
article
|
| 300 |
P039 Urine biomarkers in cancer detection: a systematic review of preanalytical parameters and applied methods with focus on breast cancer
|
Jordaens, S.
|
|
|
68 |
S |
p. S31
|
article
|
| 301 |
P156 Usefulness of pretreatment 1CTP levels as prognosis prediction
|
Yasukawa, M.
|
|
|
68 |
S |
p. S76
|
article
|
| 302 |
P242 Use of Acellular Pericardial Biological Mesh for Prepectoral and Dual Plane Prosthetic Breast Reconstruction Following Conservative Mastectomies
|
Varvaras, D.
|
|
|
68 |
S |
p. S111-S112
|
article
|
| 303 |
P221 Using an ultra-low dose of superparamagnetic iron oxide for sentinel lymph node detection in breast cancer patients - the MAGSNOW feasibility study
|
Mirzaei, N.
|
|
|
68 |
S |
p. S104
|
article
|
| 304 |
P011 Utility of oncotype in premenopausal women with hormonal receptor (hr) positive her2 negative early breast cancer
|
Cudós, A. Gasol
|
|
|
68 |
S |
p. S19
|
article
|
| 305 |
P299 Utility of Positron Emission Tomography in staging patients with recurrent breast cancer
|
Bichoo, R.A.
|
|
|
68 |
S |
p. S134
|
article
|
| 306 |
P190 Volume Replacement with Acellular Dermal Matrix Versus Absorbable Mesh after Breast-Conserving Surgery: A Randomized Controlled Trial
|
Lertsithichai, P.
|
|
|
68 |
S |
p. S91
|
article
|
| 307 |
P046 Whitlockite as a markerof benignityon breast microcalcifications detected by Raman Spectroscopy
|
Ceccarossi, V.
|
|
|
68 |
S |
p. S33
|
article
|
| 308 |
P086 5 years case series review of the impact of Combined Reverse abdominoplasty flap in reconstruction of anterior chest wall defects post extensive mastectomies
|
Sallam, I.
|
|
|
68 |
S |
p. S48
|
article
|
| 309 |
SA 1.2 Access to evidence based radiation therapy for patients with early breast cancer
|
Poortmans, P.
|
|
|
68 |
S |
p. S1
|
article
|
| 310 |
SA 4.4 Adjuvant systemic therapy for patients with germline BRCA1/2 mutations
|
Tutt, A.
|
|
|
68 |
S |
p. S4-S5
|
article
|
| 311 |
SA 2.4 Assessing clinical utility and clinical validity of biomarkers in clinical trials
|
Regan, M.
|
|
|
68 |
S |
p. S3
|
article
|
| 312 |
SA 8.1 Assessing HER2 heterogeneity
|
Penault-Llorca, F.
|
|
|
68 |
S |
p. S8
|
article
|
| 313 |
SA 7.2 Axillary surgery in the adjuvant setting
|
de Boniface, J.
|
|
|
68 |
S |
p. S7-S8
|
article
|
| 314 |
SA 6.2 Benefits and risks of oncoplastic breast-conserving surgery
|
Peeters, M.-J. Vrancken
|
|
|
68 |
S |
p. S7
|
article
|
| 315 |
SA 10.1 Breast cancer treatment and research from a global perspective
|
Anderson, B.
|
|
|
68 |
S |
p. S11
|
article
|
| 316 |
SA 10.4 Breast cancer treatment and research from a Latin American perspective
|
Bretel, D.
|
|
|
68 |
S |
p. S11
|
article
|
| 317 |
SA 10.3 Breast cancer treatment and research from an African perspective
|
Mahmoud, H. Gamal-Eldin Mohamed
|
|
|
68 |
S |
p. S11
|
article
|
| 318 |
SA 6.3 Breast surgery after neoadjuvant therapy
|
Barrio, A.V.
|
|
|
68 |
S |
p. S7
|
article
|
| 319 |
SA 6.4 Breast surgery for local recurrence
|
Rubio, I.T.
|
|
|
68 |
S |
p. S7
|
article
|
| 320 |
SA 9.4 Can we de-escalate immunotherapy and chemotherapy in TNBC?
|
Bonnefoi, H.
|
|
|
68 |
S |
p. S11
|
article
|
| 321 |
SA 11.3 Can we omit adjuvant endocrine therapy?
|
Cardoso, F.
|
|
|
68 |
S |
p. S12
|
article
|
| 322 |
SA 2.1 ctDNA dynamics for early assessment of recurrence risk
|
Turner, N.
|
|
|
68 |
S |
p. S2
|
article
|
| 323 |
SA 8.2 Current adjuvant and neoadjuvant approaches
|
Harbeck, N.
|
|
|
68 |
S |
p. S8-S9
|
article
|
| 324 |
SA 7.4 De-escalation of axillary radiotherapy - the time has come!
|
Meattini, I.
|
|
|
68 |
S |
p. S8
|
article
|
| 325 |
SA 11.4 Duration of endocrine therapy in early breast cancer
|
Huober, J.
|
|
|
68 |
S |
p. S12
|
article
|
| 326 |
SA 8.3 Emerging new treatments in HER2 positive breast cancer
|
Piccart, M.
|
|
|
68 |
S |
p. S9-S10
|
article
|
| 327 |
SA 8.4 ER positive vs ER negative: tackling diversity in HER2 positive breast cancer
|
Prat, A.
|
|
|
68 |
S |
p. S10
|
article
|
| 328 |
SA 1.5 Hot Topics in Survivorship, Patient Reported Outcomes and Quality of Life
|
Partridge, A.
|
|
|
68 |
S |
p. S2
|
article
|
| 329 |
SA 4.1 Imaging, screening & surveillance for individuals with increased hereditary breast cancer risk
|
Delaloge, S.
|
|
|
68 |
S |
p. S4
|
article
|
| 330 |
SA 5.4 Integrating new oral SERDs in the adjuvant treatment
|
Cameron, D.
|
|
|
68 |
S |
p. S6
|
article
|
| 331 |
SA 7.3 Limited axillary surgery concepts to determine nodal pathologic complete response
|
Heil, J.
|
|
|
68 |
S |
p. S8
|
article
|
| 332 |
SA 4.2 Local treatment in patients with high risk hereditary breast cancer
|
Cardoso, M.-J.
|
|
|
68 |
S |
p. S4
|
article
|
| 333 |
SA 4.3 Management of patients harboring medium penetrance genes
|
Singer, C.
|
|
|
68 |
S |
p. S4
|
article
|
| 334 |
SA 2.2 Molecular Imaging in Breast Cancer
|
van Kruchten, M.
|
|
|
68 |
S |
p. S2
|
article
|
| 335 |
SA 2.3 Multi-omic machine learning prediction of treatment response
|
Caldas, C.
|
|
|
68 |
S |
p. S3
|
article
|
| 336 |
SA 3.3 Multiplexed analysis and spatial histology to predict response
|
Kok, M.
|
|
|
68 |
S |
p. S3
|
article
|
| 337 |
SA 7.1 Omission of surgical staging of the axilla
|
Gentilini, O.D.
|
|
|
68 |
S |
p. S7
|
article
|
| 338 |
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer
|
Rugo, H.S.
|
|
|
68 |
S |
p. S10
|
article
|
| 339 |
SA 9.2 Optimal systemic therapy for residual disease in TNBC
|
Loibl, S.
|
|
|
68 |
S |
p. S10
|
article
|
| 340 |
SA 6.1 Patient selection, dose and fractionation for external beam radiotherapy in patients with early breast cancer
|
Coles, C.E.
|
|
|
68 |
S |
p. S6
|
article
|
| 341 |
SA 10.2 Perspective from Asia
|
Xu, B.
|
|
|
68 |
S |
p. S11
|
article
|
| 342 |
SA 11.1 Post-menopausal: Who needs chemotherapy in the neo (adjuvant) setting?
|
Loibl, S.
|
|
|
68 |
S |
p. S11
|
article
|
| 343 |
SA 5.1 Post-neoadjuvant options in triple negative disease: PARPi, capecitabine, checkpoint inhibitors
|
Cortes, J.
|
|
|
68 |
S |
p. S5
|
article
|
| 344 |
SA 11.2 Premenopausal HR positive breast cancer: Who needs chemotherapy in the (neo)adjuvant setting?
|
Francis, P.
|
|
|
68 |
S |
p. S12
|
article
|
| 345 |
SA 5.2 Risk assessment in ER positive disease: Who should receive CDK 4–6 inhibitors?
|
De Michele, A.
|
|
|
68 |
S |
p. S5
|
article
|
| 346 |
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?
|
Weber, W.P.
|
|
|
68 |
S |
p. S1
|
article
|
| 347 |
SA 9.3 Tackling triple negative histological subtypes in early breast cancer
|
Filho, J. Reis
|
|
|
68 |
S |
p. S11
|
article
|
| 348 |
SA 3.4 The future of breast cancer immunotherapy (PD, PDL, vaccines)
|
Curigliano, G.
|
|
|
68 |
S |
p. S3
|
article
|
| 349 |
SA 1.4 Translational research priorities for patients with early breast cancer
|
André, F.
|
|
|
68 |
S |
p. S2
|
article
|
| 350 |
SA 3.2 Tumor microenvironment in early breast cancer
|
Denkert, C.
|
|
|
68 |
S |
p. S3
|
article
|
| 351 |
SA 3.1 Understanding the anti-cancer immune response: Innate and adaptive responses to cancer cells
|
Loi, S.
|
|
|
68 |
S |
p. S3
|
article
|
| 352 |
SA 1.3 What’s new in systemic treatment of patients with early breast cancer
|
Miller, K.
|
|
|
68 |
S |
p. S1
|
article
|
| 353 |
SA 5.3 What’s next? Antibody-drug conjugates for breast cancer therapy
|
Sanz, L.
|
|
|
68 |
S |
p. S5-S6
|
article
|
| 354 |
SL 2 Pushing the boundaries for cure – extending early BC to oligometastatic?
|
Cameron, D.
|
|
|
68 |
S |
p. S12
|
article
|
| 355 |
SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
|
Tolaney, S.
|
|
|
68 |
S |
p. S3
|
article
|
| 356 |
Title Page
|
|
|
|
68 |
S |
p. i
|
article
|
Journal description